Oncology & Cancer
Study shows large-scale genomic testing feasible, impacts therapy
Targeted cancer therapy has been transforming the care of patients with non-small-cell lung cancer (NSCLC). It is now standard practice for tumor specimens from NSCLC patients to be examined for EGFR mutations and ALK rearrangements ...
Nov 15, 2012
0
0